These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33904236)

  • 41. Rationally Designed Multivalent Aptamers Targeting Cell Surface for Biomedical Applications.
    Lin M; Zhang J; Wan H; Yan C; Xia F
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):9369-9389. PubMed ID: 33146988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy.
    Orafaie A; Sadeghian H; Bahrami AR; Rafatpanah H; Matin MM
    Bioorg Med Chem; 2021 Jan; 30():115951. PubMed ID: 33360579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs.
    Hashemi M; Shamshiri A; Saeedi M; Tayebi L; Yazdian-Robati R
    Arch Biochem Biophys; 2020 Sep; 691():108485. PubMed ID: 32712288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
    Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
    Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer.
    Powell Gray B; Kelly L; Ahrens DP; Barry AP; Kratschmer C; Levy M; Sullenger BA
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4761-4766. PubMed ID: 29666232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Self-assembled amphiphilic chitosan nanomicelles to enhance the solubility of quercetin for efficient delivery.
    Wang H; Yang Z; He Z; Zhou C; Wang C; Chen Y; Liu X; Li S; Li P
    Colloids Surf B Biointerfaces; 2019 Jul; 179():519-526. PubMed ID: 31075678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation of hyaluronic acid-decorated mixed nanomicelles for targeted delivery of hydrophobic drugs to CD44-overexpressing cancer cells.
    Soleymani M; Velashjerdi M; Asgari M
    Int J Pharm; 2021 Jan; 592():120052. PubMed ID: 33159986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
    Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
    Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.
    Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z
    J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Baicalin encapsulating lipid-surfactant conjugate based nanomicelles: Preparation, characterization and anticancer activity.
    Jangid AK; Agraval H; Rai DB; Jain P; Yadav UC; Pooja D; Kulhari H
    Chem Phys Lipids; 2020 Nov; 233():104978. PubMed ID: 32991905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations.
    Jiang Y; Chen M; Nie H; Yuan Y
    Hum Vaccin Immunother; 2019; 15(5):1111-1122. PubMed ID: 30888929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-EGFR lipid micellar nanoparticles co-encapsulating quantum dots and paclitaxel for tumor-targeted theranosis.
    Kang SJ; Jeong HY; Kim MW; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Park YS
    Nanoscale; 2018 Nov; 10(41):19338-19350. PubMed ID: 30307008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular Self-Assembly of Bioorthogonal Aptamer-Prodrug Conjugate Micelles for Hydrogen Peroxide and pH-Independent Cancer Chemodynamic Therapy.
    Xuan W; Xia Y; Li T; Wang L; Liu Y; Tan W
    J Am Chem Soc; 2020 Jan; 142(2):937-944. PubMed ID: 31858794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy.
    Hamid O; Carvajal RD
    Expert Opin Biol Ther; 2013 Jun; 13(6):847-61. PubMed ID: 23421934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aptamer-mediated therapeutic strategies provide a potential approach for cancer.
    Yan B; Li Y; He S
    Int Immunopharmacol; 2024 Jul; 136():112356. PubMed ID: 38820957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles.
    Li X; Yu Y; Ji Q; Qiu L
    Nanomedicine; 2015 Jan; 11(1):175-84. PubMed ID: 25218928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors.
    Zhang D; Zheng Y; Lin Z; Liu X; Li J; Yang H; Tan W
    Angew Chem Int Ed Engl; 2020 Jul; 59(29):12022-12028. PubMed ID: 32246555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent and future advances in anticancer drug delivery: an interview with Khaled Greish.
    Greish K
    Ther Deliv; 2018 May; 9(6):409-412. PubMed ID: 29722635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Doxorubicin delivery via magnetic nanomicelles comprising from reduction-responsive poly(ethylene glycol)‑b‑poly(ε‑caprolactone) (PEG-SS-PCL) and loaded with superparamagnetic iron oxide (SPIO) nanoparticles: Preparation, characterization and simulation.
    Mousavi SD; Maghsoodi F; Panahandeh F; Yazdian-Robati R; Reisi-Vanani A; Tafaghodi M
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():631-643. PubMed ID: 30184790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pH-sensitive amphiphilic chitosan-quercetin conjugate for intracellular delivery of doxorubicin enhancement.
    Mu Y; Wu G; Su C; Dong Y; Zhang K; Li J; Sun X; Li Y; Chen X; Feng C
    Carbohydr Polym; 2019 Nov; 223():115072. PubMed ID: 31427010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.